Decreasing CNPY2 expression diminishes colorectal tumor growth and development through activation of p53 pathway

American Journal of Pathology

Volumn 186, Issue 4, 2016, Pages 1015-1024

  Yan, Ping ^a   Gong, Hui ^a   Zhai, Xiaoyan ^a   Feng, Yi ^a,b   Wu, Jun ^c   He, Sheng ^a   Guo, Jian ^c   Wang, Xiaoxia ^a   Guo, Rui ^a   Xie, Jun ^a   Li, Ren Ke ^c  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b SHANXI CANCER HOSPITAL   (China)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIC FACTOR CNPY2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN P53; UNCLASSIFIED DRUG; CANOPY 2 PROTEIN, MOUSE; CNPY2 PROTEIN, HUMAN; MEMBRANE PROTEIN; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SURGERY; CANCER TISSUE; CARCINOGENESIS; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HCT116 CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE AGED; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; COLORECTAL NEOPLASMS; CYTOLOGY; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PROCEDURES; PROGNOSIS; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICE, NUDE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84962522387     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.11.012     Document Type: Article

References (30)

1. L. Staib, K.H. Link, A. Blatz, and H.G. Beger Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients: monoinstitutional experience World J Surg 26 2002 59 66
2. R. Siegel, C. Desantis, and A. Jemal Colorectal cancer statistics, 2014 CA Cancer J Clin 64 2014 104 117
3. M.E. Daly, A. Makris, M. Reed, and C.E. Lewis Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment? J Natl Cancer Inst 95 2003 1660 1673
4. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat Rev Cancer 3 2003 401 410
5. Y. Takahashi, L.M. Ellis, and M. Mai The angiogenic switch of human colon cancer occurs simultaneous to initiation of invasion Oncol Rep 10 2003 9 13
6. J. Guo, Y. Zhang, A. Mihic, S.-H. Li, Z. Sun, Z. Shao, J. Wu, R.D. Weisel, and R.-K. Li A secreted protein (Canopy 2, CNPY2) enhances angiogenesis and promotes smooth muscle cell migration and proliferation Cardiovasc Res 105 2015 383 393
7. M. Sano, T. Minamino, H. Toko, H. Miyauchi, M. Orimo, Y. Qin, H. Akazawa, K. Tateno, Y. Kayama, M. Harada, I. Shimizu, T. Asahara, H. Hamada, S. Tomita, J.D. Molkentin, Y. Zou, and I. Komuro P53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload Nature 446 2007 444 448
8. A.J. Levine, W. Hu, and Z. Feng The P53 pathway: what questions remain to be explored? Cell Death Differ 13 2006 1027 1036
9. X.X. Wang, X.Z. Li, L.Q. Zhai, Z.R. Liu, X.J. Chen, and Y. Pei Overexpression of IQGAP1 in human pancreatic cancer Hepatobiliary Pancreat Dis Int 12 2013 540 545
10. G.S. Salvesen Caspases: opening the boxes and interpreting the arrows Cell Death Differ 9 2002 3 5
11. S. Ghavami, M. Hashemi, S.R. Ande, B. Yeganeh, W. Xiao, M. Eshraghi, C.J. Bus, K. Kadkhoda, E. Wiechec, A.J. Halayko, and M. Los Apoptosis and cancer: mutations within caspase genes J Med Genet 46 2009 497 510
12. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
13. D.J. Hicklin, and L.M. Ellis Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis J Clin Oncol 23 2005 1011 1027
14. P. Nyberg, T. Salo, and R. Kalluri Tumor microenvironment and angiogenesis Front Biosci 13 2008 6537 6553
15. B.C. Bornhauser, and D. Lindholm MSAP enhances migration of C6 glioma cells through phosphorylation of the myosin regulatory light chain Cell Mol Life Sci 62 2005 1260 1266
16. B.C. Bornhauser, P.A. Olsson, and D. Lindholm MSAP is a novel MIR-interacting protein that enhances neurite outgrowth and increases myosin regulatory light chain J Biol Chem 278 2003 35412 35420
17. C.W. Pugh, and P.J. Ratcliffe Regulation of angiogenesis by hypoxia: role of the HIF system Nat Med 9 2003 677 684
18. A. Ahluwalia, and A.S. Tarnawski Critical role of hypoxia sensor-HIF-1α in VEGF gene activation: implications for angiogenesis and tissue injury healing Curr Med Chem 19 2012 90 97
19. Y. Kondo, S. Arii, A. Mori, M. Furutani, T. Chiba, and M. Imamura Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line Clin Cancer Res 6 2000 622 630
20. P. Ferroni, R. Palmirotta, A. Spila, F. Martini, V. Formica, I. Portarena, G. Del Monte, O. Buonomo, M. Roselli, and F. Guadagni Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer Oncology 71 2006 176 184
21. M. Moehler, C. Frings, A. Mueller, I. Gockel, C.C. Schimanski, S. Biesterfeld, P.R. Galle, and M.H. Holtmann VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab World J Gastroenterol 14 2008 4156 4167
22. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
23. E.S. Kim, A. Serur, J. Huang, C.A. Manley, K.W. McCrudden, J.S. Frischer, S.Z. Soffer, L. Ring, T. New, S. Zabski, J.S. Rudge, J. Holash, G.D. Yancopoulos, J.J. Kandel, and D.J. Yamashiro Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma Proc Natl Acad Sci U S A 99 2002 11399 11404
24. T. Inai, M. Mancuso, H. Hashizume, F. Baffert, A. Haskell, P. Baluk, D.D. Hu-Lowe, D.R. Shalinsky, G. Thurston, G.D. Yancopoulos, and D.M. McDonald Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts Am J Pathol 165 2004 35 52
25. P. Carmeliet, and R.K. Jain Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases Nat Rev Drug Discov 10 2011 417 427
26. A.X. Zhu, D.V. Sahani, D.G. Duda, E. di Tomaso, M. Ancukiewicz, O.A. Catalano, V. Sindhwani, L.S. Blaszkowsky, S.S. Yoon, J. Lahdenranta, P. Bhargava, J. Meyerhardt, J.W. Clark, E.L. Kwak, A.F. Hezel, R. Miksad, T.A. Abrams, P.C. Enzinger, C.S. Fuchs, D.P. Ryan, and R.K. Jain Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study J Clin Oncol 27 2009 3027 3035
27. H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, W. Heim, J. Berlin, A. Baron, S. Griffing, E. Holmgren, N. Ferrara, G. Fyfe, B. Rogers, R. Ross, and F. Kabbinavar Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
28. G. Bergers, and D. Hanahan Modes of resistance to anti-angiogenic therapy Nat Rev Cancer 8 2008 592 603
29. J.M.L. Ebos, C.R. Lee, W. Cruz-Munoz, G.A. Bjarnason, J.G. Christensen, and R.S. Kerbel Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis Cancer Cell 15 2009 232 239
30. M. Pàez-Ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama, F. Viñals, M. Inoue, G. Bergers, D. Hanahan, and O. Casanovas Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell 15 2009 220 231